文献速递产科

一步法与两步法妊娠期糖尿病筛查对妊娠结局的影响:一项更新的系统综述与荟萃分析

One-step vs 2-step gestational diabetes mellitus screening and pregnancy outcomes: an updated systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-03-11

该系统综述与荟萃分析纳入7项随机对照试验共54,650例参与者,比较一步法与两步法筛查妊娠期糖尿病(GDM)的母婴结局。一步法组与两步法组大于胎龄儿风险无显著差异(RR 0.99,95%CI 0.93-1.05,I²=0%),但一步法组新生儿低血糖、新生儿重症监护病房入院及母体GDM诊断率均高于两步法组。

要点

  • 一步法与两步法筛查的大于胎龄儿风险无显著差异(RR 0.99,95%CI 0.93-1.05)。
  • 一步法组新生儿低血糖(RR 1.24)、新生儿重症监护病房入院(RR 1.13)及母体GDM诊断(RR 1.73)风险均高于两步法组。
  • 在随机化前筛查所有患者并排除孕前糖尿病的研究中,一步法组巨大儿风险更高(RR 1.27,95%CI 1.21-1.34)。

核心结论

  • 一步法筛查与两步法筛查相比,大于胎龄儿风险无显著差异(RR 0.99,95%CI 0.93-1.05,I²=0%)。
  • 随机分配至一步法筛查的患者新生儿低血糖(RR 1.24,95%CI 1.14-1.34,I²=0%)、新生儿重症监护病房入院(RR 1.13,95%CI 1.04-1.21,I²=0%)及母体GDM诊断(RR 1.73,95%CI 1.44-2.09,I²=80%)风险均高于两步法组。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Scopus、Cochrane、ClinicalTrials.gov和LILACS数据库,从建库至2022年9月。
  • 仅纳入随机对照试验,排除人群重叠的研究(PROSPERO注册号:CRD42022358903)。
  • 共检索到394条引文,最终纳入7项随机对照试验,总计54,650例参与者,其中一步法筛查组27,163例,两步法筛查组27,487例。
  • 两位作者计算风险比(RR)及95%置信区间(CI),并请求获取未发表数据。

主要发现

  • 大于胎龄儿(主要结局):一步法组与两步法组无显著差异(RR 0.99,95%CI 0.93-1.05,I²=0%)。
  • 新生儿低血糖:一步法组发生率高于两步法组(RR 1.24,95%CI 1.14-1.34,I²=0%)。
  • 新生儿重症监护病房入院:一步法组高于两步法组(RR 1.13,95%CI 1.04-1.21,I²=0%)。
  • 母体GDM诊断:一步法组高于两步法组(RR 1.73,95%CI 1.44-2.09,I²=80%)。
  • 在随机化前筛查所有患者并排除孕前糖尿病的研究中,一步法组新生儿巨大儿风险更高(RR 1.27,95%CI 1.21-1.34,I²=0%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This was a systematic review and meta-analysis comparing maternal and neonatal outcomes of patients screened with the 1-step or 2-step screening method for gestational diabetes mellitus. DATA SOURCES: PubMed, Scopus, Cochrane, ClinicalTrials.gov, and LILACS were searched from inception up to September 2022. STUDY ELIGIBILITY CRITERIA: Only randomized controlled trials were included. Studies that had overlapping populations were excluded (International Prospective Register of Systematic Review registration number: CRD42022358903). METHODS: Risk ratios were computed with 95% confidence intervals by 2 authors. Unpublished data were requested. Large for gestational age was the primary outcome. RESULTS: The search yielded 394 citations. Moreover, 7 randomized controlled trials met the inclusion criteria. A total of 54,650 participants were screened for gestational diabetes mellitus by either the 1-step screening method (n=27,163) or the 2-step screening method (n=27,487). For large for gestational age, there was no significant difference found between the groups (risk ratio, 0.99; 95% confidence interval, 0.93-1.05; I2=0%). Newborns of patients who underwent 1-step screening had higher rates of neonatal hypoglycemia (risk ratio, 1.24; 95% confidence interval, 1.14-1.34; I2=0%) and neonatal intensive care unit admissions (risk ratio, 1.13; 95% confidence interval, 1.04-1.21; I2=0%) than newborns of patients who underwent 2-step screening. Patients in the 1-step screening method group were more likely to be diagnosed with gestational diabetes mellitus (risk ratio, 1.73; 95% confidence interval, 1.44-2.09; I2=80%) than patients in the 2-step screening method group. In addition, among trials that tested all patients before randomization and excluded patients with pregestational diabetes mellitus, newborns were more likely to have macrosomia (risk ratio, 1.27; 95% confidence interval, 1.21-1.34; I2=0%). Overall risk of bias assessment was of low concern. CONCLUSION: Large for gestational age did not differ between patients screened using the 1-step screening method and those screened using the 2-step screening method. However, patients randomized to the 1-step screening method had higher rates of neonatal hypoglycemia and neonatal intensive care unit admission and maternal gestational diabetes mellitus diagnosis than the patients randomized to the 2-step screening method.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Gomes C, Futterman ID, Sher O, et al. One-step vs 2-step gestational diabetes mellitus screening and pregnancy outcomes: an updated systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2024. PMID: 38479488. doi:10.1016/j.ajogmf.2024.101346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。